Comparison of the Effects of Cervical Vasopressin Versus no Premedication on Blood Loss During Vaginal Hysterectomy: A Randomized, Placebo Controlled Trial
Effects of Cervical Vasopressin Versus no Premedication on Blood Loss During Vaginal Hysterectomy
Sponsor: Ascher-Walsh, Charles, M.D.
Listed as NCT00799292, this PHASE4 trial focuses on Blood Loss During Vaginal Hysterectomy and remains completed. Sponsored by Ascher-Walsh, Charles, M.D., it has been updated 7 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Apr 2022 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Apr 2022 [monthly]
Completed PHASE4
-
Aug 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Jan 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ascher-Walsh, Charles, M.D.
For direct contact, visit the study record on ClinicalTrials.gov .